2m 2m 2m 2m 2m 2m 2m
PRO-DEX (PDEX)
NASDAQ
$62.71-$0.10 (-0.16%)
Price as of Sep 11, 2026 7:30 PM EDT- $201.2MMarket Cap
- 89.92%1-Year Change
- Medical Instruments & SuppliesIndustry
PRO-DEX (PDEX)
$62.71-$0.10 (-0.16%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 77.5M +16.45% | 66.6M +23.68% | 53.8M +16.83% | 46.1M +9.62% | |
Cost of Revenue | 53.2M +13.02% | 47.1M +19.83% | 39.3M +17.86% | 33.3M +15.32% | |
Gross Profit | 24.3M +24.73% | 19.5M +34.08% | 14.6M +14.13% | 12.7M -2.92% | |
Sales and Marketing Expense | 8.0M +2,225.29% | 344,000 +194.02% | 117,000 -24.52% | 155,000 +70.33% | |
Research and Development Expense | -3.3M -8.00% | -3.6M +14.02% | -3.2M +13.73% | -2.8M -5.91% | |
Depreciation and Amortization Expense | 1.4M +12.51% | 1.2M +6.81% | 1.2M +35.36% | 857,000 +18.04% | |
Total Operating Expenses | 11.3M +28.60% | 8.8M +19.56% | 7.4M +5.60% | 7.0M -12.76% | |
Operating Profit | 13.0M +21.54% | 10.7M +49.02% | 7.2M +24.49% | 5.8M +12.47% | |
Interest Income | 181,000 +120.73% | 82,000 -43.06% | 144,000 -51.02% | 294,000 +286.84% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -533,000 +14.87% | |
Interest Income and Expense and Net | 181,000 +120.73% | 82,000 -43.06% | 144,000 +160.25% | -239,000 -38.40% | |
Total Nonoperating Income and Expense | 5.0M +266.98% | 1.4M +130.16% | -4.5M -223.81% | 3.7M +979.14% | |
Income before Taxes | 18.0M +49.40% | 12.1M +357.78% | 2.6M -72.06% | 9.4M +100.34% | |
Income Taxes | 4.4M +41.33% | 3.1M +507.50% | 507,000 -78.46% | 2.4M +176.62% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 0 -100.00% | 155,000 -92.71% | 2.1M -69.93% | 7.1M +83.50% | |
Net Income from Continuing Operations Applicable to Common | 18.0M +49.40% | 12.1M +357.78% | 2.6M -72.06% | 9.4M +100.34% | |
Basic EPS and Net Income | 4.24 +55.31% | 2.73 +347.54% | 0.61 -69.19% | 1.98 +86.79% | |
Diluted EPS and Net Income | 4.12 +54.31% | 2.67 +345.00% | 0.60 -69.23% | 1.95 +91.18% | |
Basic Weighted Average Shares | 3.2M -1.88% | 3.3M -6.03% | 3.5M -2.02% | 3.6M -1.78% | |
Diluted Weighted Average Shares | 3.3M -1.31% | 3.4M -5.88% | 3.6M -1.81% | 3.6M -3.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.2M +1,855.13% | 419,000 -84.07% | 2.6M -10.39% | 2.9M +245.82% | |
Short-Term Investments | 1.1M -82.94% | 6.7M +59.83% | 4.2M +271.87% | 1.1M +50.20% | |
Cash and Cash Equivalents and Short-Term Investments | 9.3M +30.49% | 7.2M +4.54% | 6.8M +68.26% | 4.1M +153.74% | |
Total Current Assets | 53.2M +12.59% | 47.3M +29.18% | 36.6M +18.18% | 31.0M -0.60% | |
Accumulated Depreciation | 11.6M +11.95% | 10.3M +11.71% | 9.3M +11.47% | 8.3M -0.40% | |
Property and Plant and Equipment and Net | 11.3M +1.12% | 11.2M +0.31% | 11.2M -1.32% | 11.3M +1.36% | |
Total Long-Term Assets | 60,000 +36.36% | 44,000 +4.76% | 42,000 0.00% | 42,000 0.00% | |
Total Assets | 74.5M +21.76% | 61.2M +16.61% | 52.5M +1.26% | 51.8M +9.50% | |
Income Taxes Payable | 124,000 -33.33% | 186,000 -70.57% | 632,000 +37.09% | 461,000 -15.26% | |
Total Short-Term Debt | 4.2M -31.60% | 6.1M +40.56% | 4.4M +14.29% | 3.8M +16.50% | |
Total Current Liabilities | 13.0M -11.25% | 14.6M +13.47% | 12.9M +33.24% | 9.7M -14.78% | |
Total Long-Term Debt | 13.3M -27.21% | 18.2M +141.85% | 7.5M -15.43% | 8.9M -13.06% | |
Total Long-Term Liabilities | 13.9M +39.90% | 9.9M +13.91% | 8.7M -17.42% | 10.6M -14.20% | |
Total Liabilities | 26.9M +9.43% | 24.6M +13.65% | 21.6M +6.81% | 20.2M -14.48% | |
Retained Earnings | 47.6M +32.58% | 35.9M +33.31% | 26.9M +8.57% | 24.8M +55.28% | |
Total Stockholders Equity | N/A N/A | 36.6M +18.68% | 30.9M -2.29% | 31.6M +33.47% | |
Total Shares Outstanding | 3.2M -2.30% | 3.3M -3.04% | 3.4M -5.13% | 3.5M -1.41% | |
Cash Flow | |||||
Cash from Operating Activities | 7.2M +530.56% | -1.7M -127.13% | 6.2M +13.49% | 5.5M +744.86% | |
Capital Expenditures | 483,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 3.9M +1,744.12% | -238,000 -89.34% | -2.2M +152.32% | -885,000 -28.34% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -3.4M +1,058.22% | -292,000 -93.16% | -4.3M +71.53% | -2.5M +215.19% | |
Financials Ratio | |||||
Gross Margin | 31.38% +7.11% | 29.30% +8.41% | 27.02% -2.31% | 27.66% -11.44% | |
Operating Margin | 16.75% +4.37% | 16.05% +20.49% | 13.32% +6.55% | 12.50% +2.60% | |
Return on Assets | 0.00% -100.00% | 0.27% -93.31% | 4.08% -71.42% | 14.27% +62.21% | |
Return on Equity | N/A N/A | 0.46% -93.26% | 6.81% -73.40% | 25.60% +45.29% | |
Revenue Growth | 16.45% -30.52% | 23.68% +40.68% | 16.83% +74.89% | 9.62% -8.78% | |
Current Ratio | 4.10 +26.86% | 3.23 +13.85% | 2.84 -11.30% | 3.20 +16.64% | |
Cash Ratio | 0.63 +2,106.29% | 0.03 -85.99% | 0.20 -32.73% | 0.30 +305.61% | |
Debt-to-Equity Ratio | N/A N/A | 0.67 +72.47% | 0.39 -4.32% | 0.40 -29.50% | |
Debt-to-Assets Ratio | 0.23 -41.12% | 0.40 +75.46% | 0.23 -7.65% | 0.25 -14.06% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow